Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Quarterly figures for Pure Bioscience, Inc., with source filings when available.
63 quarters. Oct 31, 2010 to Apr 30, 2026. USD.
Pure Bioscience, Inc. has filed its 10-Q within 45 to 47 days of period end across its last 8 quarters. The 10-K runs 69 to 91 days.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q3 2026 | Apr 30, 2026 | Jun 15, 2026 · after-hours | Jun 15, 2026 | 46 d | 10-Q | $506.00K | +3.1% | -$0.01 | |
| Q2 2026 |
|---|
| Jan 31, 2026 |
| Mar 16, 2026 · after-hours |
| Mar 17, 2026 |
| 45 d |
| 10-Q |
| $444.00K |
| +13.6% |
| -$0.01 |
| Q1 2026 | Oct 31, 2025 | Dec 15, 2025 · after-hours | Dec 15, 2025 | 45 d | 10-Q | $708.00K | +27.3% | $0.00 |
|---|
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Jul 31, 2025 | Oct 29, 2025 · after-hours | Oct 29, 2025 | 90 d | 10-K | $764.00K | +61.2% | — | |
| Q3 2025 | Apr 30, 2025 | Jun 16, 2025 · after-hours | Jun 16, 2025 | 47 d | 10-Q | $491.00K | +11.3% | -$0.01 | |
| Q2 2025 | Jan 31, 2025 | Mar 17, 2025 · after-hours | Mar 17, 2025 | 45 d | 10-Q | $391.00K | +19.9% | -$0.01 | |
| Q1 2025 | Oct 31, 2024 | Dec 16, 2024 · after-hours | Dec 16, 2024 | 46 d | 10-Q | $556.00K | −23.0% | -$0.01 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Jul 31, 2024 | Oct 29, 2024 · after-hours | Oct 29, 2024 | 90 d | 10-K | $474.00K | −21.3% | — | |
| Q3 2024 | Apr 30, 2024 | Jun 14, 2024 · after-hours | Jun 14, 2024 | 45 d | 10-Q | $441.00K | +8.4% | -$0.01 | |
| Q2 2024 | Jan 31, 2024 | Mar 18, 2024 · after-hours | Mar 18, 2024 | 47 d | 10-Q | $326.00K | −17.9% | -$0.01 | |
| Q1 2024 | Oct 31, 2023 | Dec 14, 2023 · after-hours | Dec 14, 2023 | 44 d | 10-Q | $722.00K | +53.3% | -$0.01 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Jul 31, 2023 | — | Oct 30, 2023 | 91 d | 10-K | $602.00K | +46.1% | — | |
| Q3 2023 | Apr 30, 2023 | Jun 14, 2023 · after-hours | Jun 14, 2023 | 45 d | 10-Q | $407.00K | −22.3% | -$0.01 | |
| Q2 2023 | Jan 31, 2023 | Mar 17, 2023 · after-hours | Mar 17, 2023 | 45 d | 10-Q | $397.00K | −4.6% | -$0.02 | |
| Q1 2023 | Oct 31, 2022 | Dec 14, 2022 · after-hours | Dec 14, 2022 | 44 d | 10-Q | $471.00K | −6.0% | -$0.01 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Jul 31, 2022 | Oct 28, 2022 · after-hours | Oct 28, 2022 | 89 d | 10-K | $412.00K | −52.0% | — | |
| Q3 2022 | Apr 30, 2022 | Jun 14, 2022 · after-hours | Jun 14, 2022 | 45 d | 10-Q | $524.00K | −6.6% | — | |
| Q2 2022 | Jan 31, 2022 | Mar 15, 2022 · after-hours | Mar 15, 2022 | 43 d | 10-Q | $416.00K | −54.6% | -$0.01 | |
| Q1 2022 | Oct 31, 2021 | — | Dec 15, 2021 | 45 d | 10-Q | $501.00K | −68.5% | -$0.01 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Jul 31, 2021 | — | Oct 28, 2021 | 89 d | 10-K | $859.00K | −78.2% | — | |
| Q3 2021 | Apr 30, 2021 | — | Jun 15, 2021 | 46 d | 10-Q | $561.00K | −74.7% | -$0.01 | |
| Q2 2021 | Jan 31, 2021 | — | Mar 15, 2021 | 43 d | 10-Q | $916.00K | +162.5% | -$0.01 | |
| Q1 2021 | Oct 31, 2020 | — | Dec 15, 2020 | 45 d | 10-Q | $1.59M | +299.7% | $0.00 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Jul 31, 2020 | — | Oct 8, 2020 | 69 d | 10-K | $3.95M | +544.2% | — | |
| Q3 2020 | Apr 30, 2020 | — | Jun 11, 2020 | 42 d | 10-Q | $2.22M | +611.9% | $0.01 | |
| Q2 2020 | Jan 31, 2020 | — | Mar 12, 2020 | 41 d | 10-Q | $349.00K | −11.4% | -$0.01 | |
| Q1 2020 | Oct 31, 2019 | — | Dec 13, 2019 | 43 d | 10-Q | $398.00K | −32.5% | -$0.01 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Jul 31, 2019 | — | Oct 30, 2019 | 91 d | 10-K | $613.00K | +20.4% | — | |
| Q3 2019 | Apr 30, 2019 | — | Jun 13, 2019 | 44 d | 10-Q | $312.00K | −20.0% | -$0.03 | |
| Q2 2019 | Jan 31, 2019 | — | Mar 6, 2019 | 34 d | 10-Q | $394.00K | −4.1% | -$0.02 | |
| Q1 2019 | Oct 31, 2018 | — | Dec 13, 2018 | 43 d | 10-Q | $590.00K | +27.2% | -$0.04 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Jul 31, 2018 | — | Oct 25, 2018 | 86 d | 10-K | $509.00K | −1.2% | — | |
| Q3 2018 | Apr 30, 2018 | — | Jun 13, 2018 | 44 d | 10-Q | $390.00K | +15.4% | -$0.02 | |
| Q2 2018 | Jan 31, 2018 | — | Mar 14, 2018 | 42 d | 10-Q | $411.00K | −8.1% | -$0.03 | |
| Q1 2018 | Oct 31, 2017 | — | Dec 14, 2017 | 44 d | 10-Q | $464.00K | −12.6% | -$0.04 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Jul 31, 2017 | — | Oct 26, 2017 | 87 d | 10-K | $515.00K | −1.7% | — | |
| Q3 2017 | Apr 30, 2017 | — | Jun 8, 2017 | 39 d | 10-Q | $338.00K | −16.1% | -$0.03 | |
| Q2 2017 | Jan 31, 2017 | — | Mar 2, 2017 | 30 d | 10-Q | $447.00K | +154.0% | -$0.01 | |
| Q1 2017 | Oct 31, 2016 | — | Dec 14, 2016 | 44 d | 10-Q | $531.00K | +185.5% | -$0.03 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Jul 31, 2016 | — | Oct 27, 2016 | 88 d | 10-K | $524.00K | +127.8% | — | |
| Q3 2016 | Apr 30, 2016 | — | Jun 9, 2016 | 40 d | 10-Q | $403.00K | +269.7% | -$0.02 | |
| Q2 2016 | Jan 31, 2016 | — | Mar 9, 2016 | 38 d | 10-Q | $176.00K | −35.5% | -$0.19 | |
| Q1 2016 | Oct 31, 2015 | — | Dec 10, 2015 | 40 d | 10-Q | $186.00K | +59.0% | -$0.07 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Jul 31, 2015 | — | Oct 28, 2015 | 89 d | 10-K | $230.00K | +72.9% | — | |
| Q3 2015 | Apr 30, 2015 | — | Jun 11, 2015 | 42 d | 10-Q | $109.00K | −58.2% | -$0.05 | |
| Q2 2015 | Jan 31, 2015 | — | Mar 4, 2015 | 32 d | 10-Q | $273.00K | +565.9% | -$0.04 | |
| Q1 2015 | Oct 31, 2014 | — | Dec 11, 2014 | 41 d | 10-Q | $117.00K | +1.7% | -$0.05 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Jul 31, 2014 | — | Oct 28, 2014 | 89 d | 10-K | $133.00K | −29.6% | — | |
| Q3 2014 | Apr 30, 2014 | — | Jun 10, 2014 | 41 d | 10-Q | $261.00K | +1.2% | -$0.07 | |
| Q2 2014 | Jan 31, 2014 | — | Mar 13, 2014 | 41 d | 10-Q | $41.00K | −84.4% | -$0.10 | |
| Q1 2014 | Oct 31, 2013 | — | Dec 12, 2013 | 42 d | 10-Q | $115.00K | +4.5% | -$0.19 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Jul 31, 2013 | — | Oct 24, 2013 | 85 d | 10-K | $189.00K | +48.8% | — | |
| Q3 2013 | Apr 30, 2013 | — | Jun 14, 2013 | 45 d | 10-Q | $258.00K | +24.6% | -$0.14 | |
| Q2 2013 | Jan 31, 2013 | — | Feb 25, 2013 | 25 d | 10-Q | $263.00K | +19.0% | -$0.17 | |
| Q1 2013 | Oct 31, 2012 | — | Dec 11, 2012 | 41 d | 10-Q | $110.00K | −57.2% | -$0.25 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Jul 31, 2012 | — | Oct 29, 2012 | 90 d | 10-K | $127.00K | −48.2% | — | |
| Q3 2012 | Apr 30, 2012 | — | Jun 13, 2012 | 44 d | 10-Q | $207.00K | +61.7% | -$0.31 | |
| Q2 2012 | Jan 31, 2012 | — | Mar 16, 2012 | 45 d | 10-Q | $221.00K | +225.0% | -$0.41 | |
| Q1 2012 | Oct 31, 2011 | — | Dec 15, 2011 | 45 d | 10-Q | $257.00K | +1,017.4% | -$0.47 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Jul 31, 2011 | — | Oct 31, 2011 | 92 d | 10-K | $245.00K | — | — | |
| Q3 2011 | Apr 30, 2011 | — | Jun 13, 2011 | 44 d | 10-Q | $128.00K | — | -$0.05 | |
| Q2 2011 | Jan 31, 2011 | — | Mar 17, 2011 | 45 d | 10-Q | $68.00K | — | -$0.07 | |
| Q1 2011 | Oct 31, 2010 | — | Dec 15, 2010 | 45 d | 10-Q | $23.00K | — | -$0.06 | |
